A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems-Reference-Cited by-同舟云学术

A novel cell-penetrating peptide derived from WT1 enhances p53 activity, induces cell senescence and displays antimelanoma activity in xeno- and syngeneic systems

Published:2014-01-01 Issue:1 Volume:4 Page:153-161
ISSN:2211-5463
Container-title:FEBS Open Bio
language:en
Short-container-title:

Author:

Massaoka Mariana H.,Matsuo Alisson L.,Figueiredo Carlos R.,Girola Natalia,Faria Camyla F.,Azevedo Ricardo A.,Travassos Luiz R.

Funder

State of São Paulo Research Support Foundation (FAPESP)

Publisher

Wiley

Subject

General Biochemistry, Genetics and Molecular Biology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1016/j.fob.2014.01.007/fullpdf

Reference59 articles.

1. A tumor suppressor and oncogene: the WT1 story;Yang;Leukemia,2007

2. Isolation and characterization of a zinc finger polypeptide gene at the human chromosome 11 Wilms’ tumor locus;Call;Cell,1990

3. WT1 mutations contribute to abnormal genital system development and hereditary Wilms’ tumour;Pelletier;Nature,1991

4. Immunohistochemical detection of WT1 protein in a variety of cancer cells;Nakatsuka;Mod. Pathol.,2006

5. Expression of the Wilms’ tumor gene WT1 in solid tumors and its involvement in tumor cell growth;Oji;Jpn. J. Cancer Res.,1999

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Peptides of yeast Saccharomyces cerevisiae activated by the malt sprout extract: Preparation, identification and bioactivity;Food Bioscience;2024-10

2. Peptide L13S Derived from the BRN2 POU Domain Reduces MetastasisIn Vivoand Inhibits Cell Migration and InvasionIn Vitro;Anticancer Research;2023-12-30

3. From antimicrobial to anticancer: the pioneering works of Prof. Luiz Rodolpho Travassos on bioactive peptides;Brazilian Journal of Microbiology;2023-09-19

4. A Nucleus-Targeting WT1 Antagonistic Peptide Encapsulated in Polymeric Nanomicelles Combats Refractory Chronic Myeloid Leukemia;Pharmaceutics;2023-09-12

5. Designed hybrid anticancer nuclear-localized peptide inhibits aggressive cancer cell proliferation;RSC Medicinal Chemistry;2022